心玮医疗-B(股票代码:06609)宣布,其自主研发的自膨式颅内药物洗脱支架注册申请已正式获得中国国家药品监督管理局(NMPA)受理。这一进展标志着公司在神经介入领域的创新产品线取得重要突破,为后续商业化进程奠定基础。
心玮医疗-B(股票代码:06609)宣布,其自主研发的自膨式颅内药物洗脱支架注册申请已正式获得中国国家药品监督管理局(NMPA)受理。这一进展标志着公司在神经介入领域的创新产品线取得重要突破,为后续商业化进程奠定基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.